Abstract
The protein serine/threonine phosphatases-1 and -2A are major cellular phosphatases, playing a fundamental role in organisms from prokaryotes to eukaryotes. They contribute to 90% dephosphorylation in eukaryote proteins. In the eye, both phosphatases are highly expressed and display important functions in regulating normal eye development. Moreover, they are implicated in pathogenesis through modulation of stress-induced apoptosis. Here we review the recent progresses on these aspects.
Keywords: Serine/threonine phosphatases-1 and -2A, eye development, lens differentiation, developmental apoptosis.
Current Molecular Medicine
Title:Regulation of Eye Development by Protein Serine/Threonine Phosphatases-1 and -2A
Volume: 15 Issue: 10
Author(s): L. -L. Gong, D. W. -C. Li, Y. -Z. Liu, W. -B. Liu, Z. -G. Chen, T. -H. Yang, R. -L. Qi, S. Huang, L. Zhang, L. Wang, W. -F. Hu, X. -H. Hu, W. -K. Ji, Z. -F. Wang, Q. Nie, Z. -X. Huang, X. -D. Gong and Y. Yang
Affiliation:
Keywords: Serine/threonine phosphatases-1 and -2A, eye development, lens differentiation, developmental apoptosis.
Abstract: The protein serine/threonine phosphatases-1 and -2A are major cellular phosphatases, playing a fundamental role in organisms from prokaryotes to eukaryotes. They contribute to 90% dephosphorylation in eukaryote proteins. In the eye, both phosphatases are highly expressed and display important functions in regulating normal eye development. Moreover, they are implicated in pathogenesis through modulation of stress-induced apoptosis. Here we review the recent progresses on these aspects.
Export Options
About this article
Cite this article as:
Gong -L. L., -C. Li W. D., Liu -Z. Y., Liu -B. W., Chen -G. Z., Yang -H. T., Qi -L. R., Huang S., Zhang L., Wang L., Hu -F. W., Hu -H. X., Ji -K. W., Wang -F. Z., Nie Q., Huang -X. Z., Gong -D. X. and Yang Y., Regulation of Eye Development by Protein Serine/Threonine Phosphatases-1 and -2A, Current Molecular Medicine 2015; 15 (10) . https://dx.doi.org/10.2174/156652401510151125125127
DOI https://dx.doi.org/10.2174/156652401510151125125127 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Development of Molecular Targeted Anticancer Agents: Successes, Failures and Future Directions
Current Pharmaceutical Design Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs
Current Drug Targets Molecular Genetics of Familial Exudative Vitreoretinopathy and Norrie Disease
Current Genomics Vascular Inflammation and Atherosclerosis: The Role of Estrogen Receptors
Current Medicinal Chemistry Changes in the Apoptotic and Survival Signaling in Cancer Cells and Their Potential Therapeutic Implications
Current Cancer Drug Targets Modulation of Sirtuins: New Targets for Antiageing
Recent Patents on CNS Drug Discovery (Discontinued) Current Targets for Anticancer Drug Discovery
Current Drug Targets Heterocyclic Scaffolds: Centrality in Anticancer Drug Development
Current Drug Targets Cyclin-Dependent Kinase as a Novel Therapeutic Target: An Endless Story
Current Chemical Biology Role of Microtubules Network in CYP Genes Expression
Current Drug Metabolism Molecular Targeted Approaches to Cancer Therapy and Prevention Using Chalcones
Current Cancer Drug Targets Cdk5 in the Adult Non-Demented Brain
Current Drug Targets - CNS & Neurological Disorders Advanced Glycation End Products: Association with the Pathogenesis of Diseases and the Current Therapeutic Advances
Current Clinical Pharmacology Integrins: Regulators of Tissue Function and Cancer Progression
Current Pharmaceutical Design Exploiting Novel Cell Cycle Targets in the Development of Anticancer Agents
Current Cancer Drug Targets Inhibition of RET Activated Pathways: Novel Strategies for Therapeutic Intervention in Human Cancers
Current Pharmaceutical Design Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies
Current Cancer Drug Targets An Integrative Systems Analysis of High-grade Glioma Cell Lines: TLRs, Wnt, BRCA1, Netrins, STXBP1 and MDH1 Provide Putative Molecular Targets for Therapeutic Intervention
Current Pharmacogenomics and Personalized Medicine Emerging Treatments in Acute Lymphoblastic Leukemia
Current Cancer Drug Targets Nanomaterials and Stem Cell Differentiation Potential: An Overview of Biological Aspects and Biomedical Efficacy
Current Medicinal Chemistry